A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX in Comparison With 150 IU Gonal-f in Women Undergoing ICSI Treatment.
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2014
Price : $35 *
At a glance
- Drugs Follicle-stimulating hormone glyco-optimised (Primary) ; Follitropin alfa
- Indications Female infertility
- Focus Biomarker; Pharmacodynamics
- Sponsors Glycotope
- 26 Mar 2014 Status changed from active, no longer recruiting to completed, as per European Clinical Trials Database record.
- 19 Jun 2013 The trial is expected to report at the beginning of the fourth quarter of 2013, according to a Glycotope media release.
- 19 Jun 2013 Status changed from recruiting to active, no longer recruiting, according to a Glycotope media release.